<unk>  is used for short-term treatment of erosion and ulceration of the esophagus for adults and children five years of age and older caused by gastroesophageal reflux disease. It can be used as a maintenance therapy for long-term use after initial response is obtained, but there have not been any controlled studies about the use of<unk>  past a duration of 12 months.<unk>  may also be used in combination with antibiotics to treat ulcers caused by Helicobacter pylori. It can also be used for long-term treatment of Zollinger-Ellison syndrome. It may be used to prevent gastric ulcers in those taking NSAIDs. Children<unk>  is only indicated for the short-term treatment of erosive esophagitis in children ages seven and older; and the safety and effectiveness of<unk>  have only been established in the treatment of erosive esophagitis in children. Elderly The incidence of adverse effects occurring in people aged 65 years and older was similar to that in people aged 65 years and less. Pregnancy In reproductive studies using doses largely greater than the recommended doses performed on rats and rabbits, there was no evident harm on the development of the baby. Breast feeding<unk>  has been found to pass through the breast milk. However, in rodent cancer studies,<unk>  has been shown to potentially cause tumor growth. The clinical relevance of the finding is unknown, but risks and benefits are recommended for consideration in determining the use of therapy for the mother and child.
Pantoprazole
Lansoprazole
Dexlansoprazole
Tenatoprazole
Rabeprazole
Omeprazole
Esomeprazole
Ranitidine